{"meta":{"query_hash":"e94fcf757b86","filters":{"venue":"Critical Reviews in Therapeutic Drug Carrier Systems"},"cohort_total":5,"direct_labels_cover":0,"predictions_cover":5,"exported":5,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/e94fcf757b86","api":"https://metacan.xera.ac/api/v1/cohort?venue=Critical+Reviews+in+Therapeutic+Drug+Carrier+Systems"},"results":[{"id":"W1973881933","doi":"10.1615/critrevtherdrugcarriersyst.2013007419","title":"A Pharmacokinetic Overview of Nanotechnology-Based Drug Delivery Systems: An ADME-Oriented Approach","year":2013,"lang":"en","type":"review","venue":"Critical Reviews in Therapeutic Drug Carrier Systems","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"ADME; Pharmacokinetics; Drug delivery; Drug; Pharmacology; Distribution (mathematics); Medicine; Nanotechnology; Materials science; Mathematics","score_opus":0.09040764381028385,"score_gpt":0.3655532596398149,"score_spread":0.275145615829531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973881933","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009849858,0.9843401,0.0008878757,0.00003168119,0.0038943563,0.008952129,0.00047019438,0.0003025731,0.00013616058],"genre_scores_gemma":[0.010155948,0.9819376,0.0004991772,0.00016402078,0.00033598638,0.006379321,0.00010194569,0.00028207613,0.00014393724],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9806674,0.008540062,0.005484564,0.0021393297,0.0013429713,0.0018256385],"domain_scores_gemma":[0.9921834,0.0017258197,0.001550169,0.0031786838,0.00063449243,0.000727449],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0067406525,0.0017102172,0.008211335,0.0009128934,0.00017314327,0.00030733983,0.0025426827,0.000844617,0.00021172262],"category_scores_gemma":[0.00065965904,0.0013163568,0.0011726125,0.0020122533,0.0011055291,0.0005569257,0.00033176923,0.0012217156,0.00062955054],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006933546,0.0019754074,0.000016744929,0.5452053,0.00026628064,0.000136469,0.00044477455,0.00020761823,0.0034243606,0.017468387,0.0013035903,0.42948171],"study_design_scores_gemma":[0.00092659396,0.00013990507,2.519895e-7,0.08732984,0.002405138,0.00012320174,0.00042147175,0.0040138206,0.00040579145,0.00008953171,0.90251386,0.0016306096],"about_ca_topic_score_codex":0.0006065447,"about_ca_topic_score_gemma":0.000010614786,"teacher_disagreement_score":0.90121025,"about_ca_system_score_codex":0.0009779332,"about_ca_system_score_gemma":0.0012552438,"threshold_uncertainty_score":0.9995644},"labels":[],"label_agreement":null},{"id":"W2020721724","doi":"10.1615/critrevtherdrugcarriersyst.v19.i1.10","title":"Pluronic? Block Copolymers in Drug Delivery: from Micellar Nanocontainers to Biological Response Modifiers","year":2002,"lang":"en","type":"review","venue":"Critical Reviews in Therapeutic Drug Carrier Systems","topic":"Advanced Polymer Synthesis and Characterization","field":"Chemistry","cited_by":437,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Supratek Pharma (Canada)","funders":"","keywords":"Poloxamer; Copolymer; Drug delivery; Drug carrier; Micelle; Chemistry; Pharmacology; Nanotechnology; Materials science; Medicine; Organic chemistry; Polymer; Aqueous solution","score_opus":0.059432426246273845,"score_gpt":0.33070139342909477,"score_spread":0.2712689671828209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020721724","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010275784,0.994714,0.00006343238,0.00011480393,0.0010476649,0.0015585594,0.00056477013,0.00008427391,0.0008248846],"genre_scores_gemma":[0.011265523,0.98488045,0.000036785757,0.0003113925,0.00037555478,0.0015168925,0.00013905636,0.00017477015,0.001299563],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9908755,0.0026909085,0.0030293001,0.0016177257,0.0004942778,0.0012923249],"domain_scores_gemma":[0.9944023,0.0030247443,0.0005118571,0.0014037574,0.00007463719,0.000582695],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0015911818,0.0012795659,0.0048251846,0.00038655897,0.000112410526,0.00016157802,0.0011908077,0.0008294363,0.0003981616],"category_scores_gemma":[0.00086784124,0.0010369521,0.0008632568,0.000775011,0.00027603013,0.00013936445,0.00019164332,0.0011210546,0.00026102725],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003631628,0.00035913318,0.00006690324,0.021215644,0.00029700994,0.00031874058,0.0018358316,0.000010277548,0.0017291642,0.00086487544,0.0006181795,0.9723211],"study_design_scores_gemma":[0.00034276338,0.000019954736,0.0000011070118,0.034016334,0.0003538022,0.000021704906,0.00067322503,0.00006258426,0.00011369035,0.000026602604,0.9632711,0.001097122],"about_ca_topic_score_codex":0.00038448098,"about_ca_topic_score_gemma":0.000045907735,"teacher_disagreement_score":0.97122395,"about_ca_system_score_codex":0.0014179182,"about_ca_system_score_gemma":0.00031356508,"threshold_uncertainty_score":0.99999565},"labels":[],"label_agreement":null},{"id":"W2029735514","doi":"10.1615/critrevtherdrugcarriersyst.v25.i6.20","title":"A Review of the Application of Lipid-Based Systems in Systemic, Dermal/ Transdermal, and Ocular Drug Delivery","year":2008,"lang":"en","type":"review","venue":"Critical Reviews in Therapeutic Drug Carrier Systems","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Transdermal; Drug delivery; Drug; Delivery system; Pharmacology; Medicine; Drug administration; Nanotechnology; Materials science","score_opus":0.1048928554599613,"score_gpt":0.44093182579256274,"score_spread":0.33603897033260144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029735514","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048976934,0.9849795,0.0013168674,0.000092632785,0.0021455875,0.010806742,0.00042180193,0.000033550168,0.00015431915],"genre_scores_gemma":[0.0121058775,0.9834938,0.000028739787,0.0007728917,0.00017900293,0.0032005499,0.000047282752,0.00012542559,0.000046409634],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9818406,0.010209636,0.0053213257,0.0010520479,0.00065669534,0.0009196882],"domain_scores_gemma":[0.99358845,0.00297763,0.0014465121,0.0013577968,0.00033295935,0.00029665534],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0044194907,0.0011022708,0.00618561,0.00041948215,0.00015027368,0.000021673615,0.001415375,0.00080659165,0.000030076382],"category_scores_gemma":[0.00036547042,0.0008047213,0.0011086912,0.0012941626,0.0011821472,0.00017231486,0.00013099935,0.002040224,0.000017706727],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003479633,0.00034503388,0.00024202965,0.75606287,0.00026120807,0.00003675453,0.00031776473,0.00013796316,0.000040834617,0.0016863302,0.0003593177,0.24047509],"study_design_scores_gemma":[0.00063432386,0.000019452136,0.000003929438,0.25274244,0.0013505602,0.00023469524,0.00007686848,0.0010372881,0.000017371714,0.000011297384,0.7433475,0.00052423327],"about_ca_topic_score_codex":0.0002660615,"about_ca_topic_score_gemma":0.000028791039,"teacher_disagreement_score":0.7429882,"about_ca_system_score_codex":0.000544615,"about_ca_system_score_gemma":0.0007880173,"threshold_uncertainty_score":0.9994404},"labels":[],"label_agreement":null},{"id":"W2049724639","doi":"10.1615/critrevtherdrugcarriersyst.v19.i45.20","title":"Current Status of DNA Vaccines and Their Route of Administration;","year":2002,"lang":"en","type":"review","venue":"Critical Reviews in Therapeutic Drug Carrier Systems","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"","keywords":"DNA vaccination; Vaccination; Medicine; Delivery system; Immunology; Risk analysis (engineering); Immunization; Immune system; Pharmacology","score_opus":0.06683106645513742,"score_gpt":0.37068677540326594,"score_spread":0.3038557089481285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049724639","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003234009,0.9974948,0.00016072084,0.0000072047565,0.0006386824,0.0008701332,0.0002767611,0.000003328285,0.0002249292],"genre_scores_gemma":[0.031384945,0.9680193,0.000008770833,0.000013433231,0.00017540064,0.00016553723,0.00007828909,0.00003130975,0.00012299434],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996948,0.000610411,0.0014908725,0.00047071368,0.0001303137,0.0003497098],"domain_scores_gemma":[0.99858797,0.00013847517,0.00037346897,0.00061067473,0.00014872344,0.00014071715],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005016421,0.00042565374,0.002006953,0.00010243326,0.000022384444,0.000025806803,0.0003091705,0.0002381475,0.000017852586],"category_scores_gemma":[0.00025863445,0.0002918397,0.00042877917,0.00016374564,0.00016145816,0.0000065858985,0.00008901415,0.00020352854,0.000004169775],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010717416,0.000092744485,0.00009249935,0.03660537,0.000119473196,0.0000015494048,0.00010030395,1.6229038e-7,0.00016553431,0.00088623475,0.00023861461,0.9616868],"study_design_scores_gemma":[0.000115569375,0.00015164628,0.0000060251014,0.015526851,0.00023575703,0.0000271222,0.00009389773,0.000008005845,0.0001522469,0.00003859361,0.98338073,0.00026352992],"about_ca_topic_score_codex":0.000018474702,"about_ca_topic_score_gemma":0.000014665058,"teacher_disagreement_score":0.98314214,"about_ca_system_score_codex":0.00003399441,"about_ca_system_score_gemma":0.00023851854,"threshold_uncertainty_score":0.9999534},"labels":[],"label_agreement":null},{"id":"W2806857987","doi":"10.1615/critrevtherdrugcarriersyst.2018024751","title":"Polymeric Lipid Hybrid Nanoparticles: Properties and Therapeutic Applications","year":2018,"lang":"en","type":"review","venue":"Critical Reviews in Therapeutic Drug Carrier Systems","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University","funders":"","keywords":"Nanocarriers; Nanotechnology; Nanoparticle; Drug delivery; Liposome; Biocompatibility; Solid lipid nanoparticle; Drug carrier; Materials science; Chemistry","score_opus":0.0771936891265074,"score_gpt":0.3306351018425274,"score_spread":0.25344141271602005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806857987","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027665193,0.99229753,0.0003922571,0.00008938933,0.0015592031,0.0049271677,0.00012169874,0.00017473249,0.00016137213],"genre_scores_gemma":[0.023986537,0.96827537,0.00005824892,0.00031746685,0.0008041741,0.0060548503,0.000009542062,0.00017191628,0.00032192556],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9909996,0.003005097,0.0026514647,0.0014909314,0.0006325261,0.0012203972],"domain_scores_gemma":[0.9961063,0.0010052314,0.000499278,0.0017196471,0.00019121438,0.00047827873],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031070772,0.0010311933,0.003629524,0.00029547722,0.00031323184,0.00053898577,0.0010925082,0.0002195125,0.00011511706],"category_scores_gemma":[0.00031512626,0.0007311056,0.00047628558,0.0008184231,0.0014010343,0.00026488196,0.0002634385,0.0005150813,0.0014383737],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024139053,0.000332287,0.00001232725,0.06352676,0.000101733254,0.000029152156,0.00043509837,0.0000010999896,0.0042700106,0.0073618437,0.00034278072,0.92356277],"study_design_scores_gemma":[0.00020775772,0.000067271045,4.3387828e-7,0.019999364,0.00092024065,0.00019172255,0.00014448384,0.000078400175,0.000894387,0.0002013923,0.9764018,0.00089274114],"about_ca_topic_score_codex":0.000082147846,"about_ca_topic_score_gemma":0.000008291596,"teacher_disagreement_score":0.976059,"about_ca_system_score_codex":0.00040489557,"about_ca_system_score_gemma":0.00053730304,"threshold_uncertainty_score":0.999514},"labels":[],"label_agreement":null}]}